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A 74-year-old woman without contributory medical history presented with acute iridocyclitis in the right eye. Although the
iridocyclitis disappeared within two weeks under topical steroid, she complained of acute progressing bilateral shoulder pain
and morning stiﬀness of upper extremities. She was diagnosed as having polymyalgia rheumatica (PMR), and iridocyclitis was
considered as its related manifestation. PMR and giant cell arteritis (GCA) are closely related conditions and frequently occur
together. GCA with uveitis has been rarely noted. However, ocular symptoms in PMR have not been previously mentioned. This
is a ﬁrst reported case of PMR presented with uveitis, without a complication of GCA. This anterior uveitis might be caused by
ischemia of the posterior ciliary arteries and their branches.
1.Introduction
Polymyalgia rheumatica (PMR) is inﬂammatory condition
of unknown cause and characterized by aching and morning
stiﬀness in the cervical region, shoulder, and pelvic girdles
[1–3]. On the other hand, in giant cell arteritis (GCA), a
chronic vasculitis of large and medium-sized vessels may
develop. Both diseases are closely related conditions that
aﬀect persons of middle age and older and frequently
occur together [2, 3]. Therefore, these may be considered
as diﬀerent phases of the same disease [2, 3]. In GCA,
ischemic visual manifestations are commonly observed [2–
4], and uveitis as its complication has been rarely reported
[5–9]. However, the relevance of ocular manifestation and
PMR has not been noted. Here, we describe a ﬁrst reported
case of PMR with acute anterior uveitis as its preceding
manifestation, though GCA was not complicated.
2.CaseReport
A 74-year-old Japanese woman without contributory med-
ical history complained of gradual blurred vision in the
right eye and consulted the ophthalmologist on September
2009. Her corrected visual acuities were 0.4 in the right eye
and 1.0 in the left. Light and near reﬂexes were brisk in
b o t he y e s .T h e r ew a sn or e l a t i v ea ﬀerent papillary defect.
Fundoscopic ﬁndings demonstrated iridocyclitis in the right
eye and no abnormalities in the left eye, respectively.
Ocular movements were not restricted. Two weeks later, her
iridocyclitis disappeared and visual acuity normalized in the
right eye with 4 times/day of topical 0.1% ﬂuorometholone.
However, she complained of duration longer than 1 hour of
morning stiﬀness in the cervical region, arms, and shoulders
bilaterally. As these symptoms gradually worsened for a
week, she was admitted to our hospital in October 2009.
In general examination, bilateral upper shoulder pain and
bilateral upper arm tenderness were observed. Moreover,
there was morning stiﬀness in the cervical region, arms,
and shoulders bilaterally with duration longer than 3 hours,
without motor weakness. Neither arthritis nor rheumatoid
noduleswere observed. There was no genitalulcer. Complete
blood cell counts demonstrated mild hypochromic micro-
cytic anemia and elevated platelet count at 48.3×104/µL. An
erythrocyte sedimentation rate (ESR) of 44 mm in the ﬁrst
hour was demonstrated. Blood examination demonstrated
anelevatedlevelofC-reactiveproteinat7.4mg/dL.However,2 Case Reports in Medicine
CK and angiotensin-converting enzyme level in the serum
was within normal ranges. Neither antinuclear antibody titer
nor rheumatoid factor was within positive ranges. Chest X-
ray examination did not demonstrate any abnormalities. 6
of 7 of Bird’s criteria was fulﬁlled for PMR [1]. because
of shoulder pain and stiﬀness bilaterally, an onset of illness
within2-weekduration,initialESRhigherthan40mm/hour,
morning stiﬀness duration longer than 1 hour, onset of
age older than 65, and upper arm tenderness bilaterally.
Moreover, rheumatoid arthritis and ankylosing spondylitis
were denied, based on her clinical course as well as physical
examination. On the other hand, she did not complain of
headache. Neither tenderness to palpation nor decreased
pulsation was observed in the bilateral temporal arteries.
Thereby, biopsy of the temporal artery was not performed.
Asaresult,shewasdiagnosed ashaving PMRwithoutacom-
plication of GCA. Then, oral prednisolone 12.5mg/day was
initiated. Then, her clinical symptoms markedly improved,
and C-reactive protein in the serum and ESR normalized
within a week. One month later from the initiation of oral
steroid therapy, complete blood cell counts improved to
within normal ranges. Thereafter, under oral prednisolone
5mg/day therapy, neitherPMR noranterior uveitisrecurred.
3.Discussion
PMR is characterized by severe bilateral pain and aching
involving the neck, the shoulder, and pelvic girdles, asso-
ciated with morning stiﬀness [1–3]. The inﬂammatory
involvementofproximalarticular andextraarticular synovial
structures is responsible for its typical symptoms [1–3]. On
the other hand, GCA is less common than PMR [2, 3].
Vasculitis that involves large and middle-sized blood vessels
with a predisposition for cranial arteries usually develops,
and ischemic visual manifestations are the most feared in
GCA [2, 3]. In addition, thrombocytosis is considered as a
risk factor of ischemic event in GCA patients [10–12]. On
the other hand, GCA patients often present with clinical
manifestation of PMR showing an incidence of 40–60% [3].
Furthermore, both GCA and PMR conditions are charac-
terized by late age at disease onset, are more common in
woman, exhibit evidenceof systemic inﬂammatory response,
and generally respond well to steroids [2, 3].
There has been no reported case of PMR presented with
uveitis, without complication of GCA. However, only 4 cases
of uveitis due to GCA have been reported [5–8]. Among
them [5–8], Bandini et al. [5] noted a case of unilateral
anterior uveitis occurring 3 weeks before GCA diagnosis
was made based on the temporal artery biopsy. Dasgupta et
al. [6] reported a case of unilateral anterior and posterior
uveitis occurring as presenting feature of GCA. Rajesh and
Cole [7] wrote a case of bilateral panuveitis one year before
the diagnosis of GCA was made based on temporal artery
biopsyﬁnding. Coppeto et al. [8] described a case ofbilateral
iritis being related to the presence of GCA. Only this case
had a past medical history of PMR [8]. In the previous
reports [5–8], uveitis disappeared under only topical [5, 6]
or systemic and topical [7, 8] steroid therapy. In addition,
V´ edrine et al. [9] noted that uveitis was an unusual common
presenting feature of GCA and anterior uveitis might be
caused by ischemia of the posterior ciliary arteries and their
branches. On the otherhand, positron emission tomography
examination suggests that PMR without complication of
GCA is a form of vasculitis [13, 14]. Moreover, even in
PMR without GCA, thrombocytosis may be a risk factor
of ocular or cerebral ischemic events [15]. In our patient,
the anterior uveitis might have developed as a preceding
clinical manifestation of PMR and disappeared under topical
steroid. Furthermore, thrombocytosis was initially observed
and gradually normalized under oral steroid therapy. From
these results, we considered that her anterior uveitis might
be caused by ischemia of the posterior ciliary arteries and
their branches, which was associated with vasculitis and/or
thrombocytosis due to a preceding disorder in PMR.
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